
HONG KONG, Sep 8, 2020 - (ACN Newswire) - Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics targeting antimicrobial resistance, today announced President and Executive Director, Mr....
Read more: Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10